NASDAQ : KRON
Kronos Bio, Inc. — Financial statements
Healthcare · Biotechnology · United States
Last price 0.88 USD (At close: Jun 20, 2025) · Market cap 53.73M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
Kronos Bio, Inc. (KRON) reported revenue of 9.19M USD (TTM). Five years of income statement, balance sheet, cash flow and ratios below.
Income statement
Fiscal year January - December; amounts in USD.
| TTM | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | |
|---|---|---|---|---|---|---|
| Revenue | 9.19M | 9.85M | 6.29M | |||
| Gross Profit | 9.19M | 9.85M | 6.29M | |||
| Selling, General & Admin | 25.41M | 27.68M | 42.29M | 46.47M | 41.80M | 19.07M |
| Research & Development | 34.38M | 45.60M | 81.20M | 90.65M | 109.59M | 38.98M |
| Operating Expenses | 59.79M | 73.28M | 123.49M | 137.12M | 151.40M | 58.04M |
| Operating Income | -50.60M | -63.43M | -117.20M | -137.12M | -151.40M | -58.04M |
| Interest Expense | -3.89M | |||||
| Interest & Investment Income | 5.85M | 6.81M | 9.40M | 320.00K | 898.00K | |
| Other Non Operating Income (Expenses) | 3.91M | |||||
| EBT Excluding Unusual Items | -44.75M | -56.62M | -107.80M | -133.20M | -151.08M | -61.04M |
| Merger & Restructuring Charges | -7.36M | -10.75M | -1.71M | |||
| Asset Writedown | -12.38M | -18.71M | -3.16M | |||
| Other Unusual Items | -27.41M | |||||
| Pretax Income | -64.48M | -86.08M | -112.67M | -133.20M | -151.08M | -88.44M |
| Net Income | -64.48M | -86.08M | -112.67M | -133.20M | -151.08M | -88.44M |
| Net Income to Common | -64.48M | -86.08M | -112.67M | -133.20M | -151.08M | -88.44M |
| Shares Outstanding (Basic) | 60.39M | 60.07M | 57.74M | 56.20M | 54.75M | 16.28M |
| Shares Outstanding (Diluted) | 60.39M | 60.07M | 57.74M | 56.20M | 54.75M | 16.28M |
| EPS (Basic) | -1.07 | -1.43 | -1.95 | -2.37 | -2.76 | -5.43 |
| EPS (Diluted) | -1.07 | -1.43 | -1.95 | -2.37 | -2.76 | -5.43 |
| Free Cash Flow | -54.38M | -65.44M | -79.26M | -91.50M | -122.18M | -47.48M |
| Free Cash Flow Per Share | -0.90 | -1.09 | -1.37 | -1.63 | -2.23 | -2.92 |
| Gross Margin | 100.00% | 100.00% | 100.00% | |||
| Operating Margin | -550.46% | -644.11% | -1,863.88% | |||
| Profit Margin | -701.53% | -874.08% | -1,791.87% | |||
| Free Cash Flow Margin | -591.55% | -664.49% | -1,260.51% | |||
| EBITDA | -49.14M | -61.72M | -115.06M | -134.85M | -149.42M | -57.20M |
| D&A For EBITDA | 1.46M | 1.72M | 2.14M | 2.27M | 1.98M | 839.00K |
| EBIT | -50.60M | -63.43M | -117.20M | -137.12M | -151.40M | -58.04M |
Balance sheet
Fiscal year January - December; amounts in USD.
| TTM | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 91.58M | 84.57M | 64.33M | 75.97M | 198.27M | 248.01M |
| Short-Term Investments | 8.16M | 27.85M | 108.67M | 162.21M | 141.24M | 165.05M |
| Cash & Short-Term Investments | 99.73M | 112.42M | 173.00M | 238.19M | 339.51M | 413.06M |
| Other Receivables | 816.00K | 612.00K | ||||
| Receivables | 816.00K | 612.00K | ||||
| Prepaid Expenses | 1.34M | 2.51M | 5.38M | 6.11M | 6.25M | 5.01M |
| Other Current Assets | 800.00K | 300.00K | 400.00K | 984.00K | 1.12M | |
| Total Current Assets | 101.87M | 115.23M | 178.78M | 244.29M | 347.55M | 419.80M |
| Property, Plant & Equipment | 4.13M | 7.00M | 29.91M | 37.69M | 41.78M | 40.97M |
| Long-Term Investments | 1.99M | 9.76M | 49.00M | |||
| Other Long-Term Assets | 2.14M | 2.14M | 2.60M | 3.19M | 2.14M | 2.19M |
| Total Assets | 108.14M | 124.36M | 213.28M | 294.94M | 391.48M | 511.96M |
| Accounts Payable | 1.57M | 2.40M | 883.00K | 5.05M | 998.00K | 4.55M |
| Accrued Expenses | 2.38M | 3.55M | 10.78M | 12.92M | 9.06M | 3.49M |
| Current Portion of Leases | 3.64M | 3.39M | 2.89M | 2.35M | 2.11M | 942.00K |
| Current Income Taxes Payable | 72.00K | 26.00K | 133.00K | 40.00K | 558.00K | |
| Current Unearned Revenue | 1.86M | 9.58M | ||||
| Other Current Liabilities | 221.00K | 4.04M | 422.00K | 1.13M | 1.46M | 3.32M |
| Total Current Liabilities | 7.88M | 15.28M | 24.70M | 21.49M | 13.63M | 12.86M |
| Long-Term Leases | 20.45M | 21.51M | 25.38M | 28.74M | 31.65M | 31.12M |
| Long-Term Unearned Revenue | 4.13M | |||||
| Other Long-Term Liabilities | 209.00K | 1.10M | 2.47M | |||
| Total Liabilities | 28.33M | 36.78M | 54.20M | 50.44M | 46.38M | 46.45M |
| Common Stock | 61.00K | 60.00K | 59.00K | 57.00K | 56.00K | 54.00K |
| Additional Paid-In Capital | 683.05M | 682.45M | 667.86M | 641.42M | 608.06M | 577.39M |
| Retained Earnings | -603.30M | -594.94M | -508.86M | -396.19M | -262.98M | -111.91M |
| Comprehensive Income & Other | 9.00K | 19.00K | -792.00K | -39.00K | -19.00K | |
| Total Common Equity | 79.81M | 87.58M | 159.08M | 244.50M | 345.10M | 465.52M |
| Shareholders' Equity | 79.81M | 87.58M | 159.08M | 244.50M | 345.10M | 465.52M |
| Total Liabilities & Equity | 108.14M | 124.36M | 213.28M | 294.94M | 391.48M | 511.96M |
| Total Debt | 24.09M | 24.90M | 28.27M | 31.09M | 33.76M | 32.06M |
| Net Cash (Debt) | 75.64M | 87.52M | 144.72M | 207.09M | 305.75M | 381.00M |
| Net Cash Per Share | 1.25 | 1.46 | 2.51 | 3.68 | 5.58 | 23.41 |
| Filing Date Shares Outstanding | 60.97M | 60.97M | 60.10M | 57.63M | 56.60M | 56.05M |
| Total Common Shares Outstanding | 60.97M | 60.46M | 58.95M | 56.97M | 55.70M | 54.07M |
| Working Capital | 93.99M | 99.95M | 154.08M | 222.81M | 333.93M | 406.95M |
| Book Value Per Share | 1.31 | 1.45 | 2.70 | 4.29 | 6.20 | 8.61 |
| Tangible Book Value | 79.81M | 87.58M | 159.08M | 244.50M | 345.10M | 465.52M |
| Tangible Book Value Per Share | 1.31 | 1.45 | 2.70 | 4.29 | 6.20 | 8.61 |
| Machinery | 370.00K | 8.28M | 8.84M | 9.15M | 8.80M | 5.83M |
| Leasehold Improvements | 4.13M | 4.14M | 8.70M | 9.35M | 9.34M | 8.96M |
Cash flow statement
Fiscal year January - December; amounts in USD.
| TTM | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | |
|---|---|---|---|---|---|---|
| Net Income | -64.48M | -86.08M | -112.67M | -133.20M | -151.08M | -88.44M |
| Depreciation & Amortization | 1.46M | 1.72M | 2.14M | 2.27M | 1.98M | 839.00K |
| Other Amortization | 3.89M | |||||
| Asset Writedown & Restructuring Costs | 19.54M | 27.63M | 3.16M | 3.56M | ||
| Loss (Gain) From Sale of Investments | -1.86M | -2.81M | -5.34M | -533.00K | 4.00M | 326.00K |
| Stock-Based Compensation | 6.03M | 9.22M | 24.98M | 31.14M | 26.21M | 3.75M |
| Other Operating Activities | 2.15M | 2.78M | 3.27M | 3.22M | 2.59M | 31.70M |
| Change in Accounts Payable | -656.00K | 1.52M | -4.15M | 4.03M | -3.19M | 2.81M |
| Change in Unearned Revenue | -11.19M | -11.85M | 13.71M | |||
| Change in Other Net Operating Assets | -5.36M | -7.57M | -3.69M | 2.15M | 1.57M | 3.65M |
| Operating Cash Flow | -54.38M | -65.44M | -78.58M | -90.93M | -117.92M | -37.91M |
| Capital Expenditures | 3.00K | -4.00K | -679.00K | -577.00K | -4.26M | -9.57M |
| Investment in Securities | 99.51M | 85.44M | 67.05M | -31.64M | 67.98M | -150.67M |
| Investing Cash Flow | 99.51M | 85.44M | 66.37M | -32.22M | 63.72M | -160.24M |
| Long-Term Debt Issued | 151.28M | |||||
| Long-Term Debt Repaid | -5.00K | -32.00K | ||||
| Net Debt Issued (Repaid) | -5.00K | 151.24M | ||||
| Issuance of Common Stock | 245.00K | 245.00K | 567.00K | 851.00K | 4.46M | 264.37M |
| Financing Cash Flow | 245.00K | 245.00K | 567.00K | 851.00K | 4.46M | 415.61M |
| Net Cash Flow | 45.38M | 20.25M | -11.65M | -122.30M | -49.74M | 217.47M |
| Free Cash Flow | -54.38M | -65.44M | -79.26M | -91.50M | -122.18M | -47.48M |
| Free Cash Flow Margin | -591.55% | -664.49% | -1,260.51% | |||
| Free Cash Flow Per Share | -0.90 | -1.09 | -1.37 | -1.63 | -2.23 | -2.92 |
| Levered Free Cash Flow | -30.66M | -30.74M | -43.82M | -43.30M | -72.40M | -35.88M |
| Unlevered Free Cash Flow | -30.66M | -30.74M | -43.82M | -43.30M | -72.40M | -37.34M |
Ratios
Fiscal year January - December; amounts in USD.
| TTM | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | |
|---|---|---|---|---|---|---|
| Market Capitalization | 57.32M | 72.90M | 92.18M | 765.76M | 1.67B | |
| Enterprise Value | -41.74M | -84.28M | -134.31M | 401.43M | 1.79B | |
| Last Close Price | 0.95 | 1.25 | 1.62 | 13.59 | 29.87 | |
| PS Ratio | 5.82 | 11.59 | ||||
| PB Ratio | 0.66 | 0.46 | 0.38 | 2.22 | 3.60 | |
| P/TBV Ratio | 0.66 | 0.46 | 0.38 | 2.22 | 3.60 | |
| Debt / Equity Ratio | 0.30 | 0.28 | 0.18 | 0.13 | 0.10 | 0.07 |
| Asset Turnover | 0.06 | 0.06 | 0.03 | |||
| Quick Ratio | 12.66 | 7.36 | 7.00 | 11.09 | 24.98 | 32.18 |
| Current Ratio | 12.93 | 7.54 | 7.24 | 11.37 | 25.51 | 32.65 |
| Return on Equity (ROE) | -59.49% | -69.80% | -55.84% | -45.18% | -37.28% | -31.30% |
| Return on Assets (ROA) | -21.73% | -23.48% | -28.83% | -24.97% | -20.95% | -11.80% |
| Return on Invested Capital (ROIC) | -23.57% | -26.45% | -31.65% | -26.19% | -21.59% | -12.14% |
| Earnings Yield | -150.16% | -154.57% | -144.51% | -19.73% | -5.28% | |
| FCF Yield | -114.16% | -108.73% | -99.27% | -15.96% | -2.84% | |
| Buyback Yield / Dilution | -3.52% | -4.03% | -2.75% | -2.64% | -236.38% | -208.35% |